More importantly, the study also showed that the expression level of CD133 could be upregulated by TGF-β via the Smad-dependent pathway in Huh7 cells, an HCC cell line known to respond to TGF-β with a robust senescence phenotype [64,256]. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.